This document provides an overview of the Ukrainian pharmaceutical market and macroeconomic environment in December 2015. It discusses key economic events in Ukraine, including approval of the 2016 budget and tax code. Macroeconomic indicators such as GDP, exports, imports, currency exchange rates, unemployment, and salaries are presented. The pharmaceutical industry section provides data on export and import of pharmaceutical products, retail pharmacy sales volumes and values, and consumer price indexes. Local pharmaceutical companies' market share is also indicated.
This document is a monthly report on the Ukrainian pharmaceutical market from March 2016. It provides key macroeconomic indicators for Ukraine from February 2015 to February 2016, including GDP growth, export/import levels, unemployment, and exchange rates. It also gives pharmaceutical industry-specific data over the same time period, such as export/import of pharmaceutical products, retail sales volumes and values, weighted average cost per pack, and the market share of local vs. foreign companies. The report concludes with a summary of recent economic events in Ukraine.
This document is a monthly report on the Ukrainian pharmaceutical market from March 2016. It provides key macroeconomic indicators for Ukraine from February 2015 to February 2016, including GDP growth, export/import levels, unemployment, and exchange rates. It also gives pharmaceutical industry-specific data over the same time period, such as export/import of pharmaceutical products, retail sales volumes and values, weighted average cost per pack, and the market share of local vs. foreign companies. The report concludes with a summary of recent economic events in Ukraine.
The pharmaceutical market of Uzbekistan is growing rapidly due to economic development and population growth. The market is currently estimated at $650-700 million but is forecast to double to $1.5 billion by 2020. Local manufacturers currently hold 20% market share while the remaining 80% is held by foreign manufacturers, primarily from Europe, the US, and India. The government is supporting development of domestic production through incentives for foreign investment. Key growth areas are expected to be generics, OTC drugs, and patented brands as consumer purchasing power increases. The market remains underdeveloped with a need for more modern medical facilities and a wider range of products across the country.
The Commonwealth of Independent States (CIS) region has a total GDP of approximately $1.6 trillion and a population of 276 million people. While the original drug market will grow more slowly than generics between 2010-2011, overall growth in original medicines will be positive. The pharmaceutical market is dominated by generic drugs, which make up around 85% of the market. Key players and market structure differ from Western markets, with almost a 50/50 split between Rx and OTC segments and strong local generic production, particularly in Ukraine.
Dear all,
I'm glad to share with you our quarterly report on M&A activities in the industrial segment, the Industrial Insider.
There is a special focus on the Industrial Internet Of Things, IOT.
Should you have any quieries, don't hesitate to contact your local Global M&A Partners' Industrials' sector team representative.
This report analyzes the pharmaceutical industry in Uruguay. Key points include:
1) The pharmaceutical sector has shown strong growth over the past decade, outpacing overall manufacturing and the national economy. Exports have also grown faster than total country exports.
2) The industry employs thousands of professionals and technicians and pays above-average wages. There are around 100 pharmaceutical companies in Uruguay, larger than average for national industries.
3) While exports have increased, imports remain greater than exports, resulting in a trade deficit. The main exports are medicines, blood products, and pharmaceutical preparations. Exports go mainly to Latin America.
4) The domestic market includes multinational and national/regional companies
The document summarizes the Ukrainian pharmaceutical market and reasons for starting a business there. It notes that Ukraine has a large pharmaceutical market with over $2.8 billion in retail sales in 2019. The market is growing in both monetary and physical terms. Foreign manufacturers are increasing their market share. Ukraine also offers low costs for doing business, a large workforce, and natural attractions for tourism. The agency provides various consulting services to help companies enter and succeed in the Ukrainian pharmaceutical market.
Global M&A Partners Industrial insider Q3 2018 focus on predictive maintenanceVeronique Zeid-Maurel
Happy to share with you our quarterly report on M&A activities in the industrial segment, there is a special focus on predictive maintenance. To know more, contact your local Global M&A Industrial sector team member. http://www.globalma.com/industry_sectors/industrials
Global M&A Industrial insider Q4 2018 industrial machine visionVeronique Zeid-Maurel
Happy to share with you our quarterly report on M&A activities in the industrial segment, there is a special focus on industrial machine vision.
To know more, contact your local Global M&A Industrial sector team member.
https://www.globalma.com/industry_sectors
Ukrainian Pharmaceutical Market Monthly - Upharmacia - Feb 2018Eirhub
This document provides an overview of macroeconomic indicators and pharmaceutical market indicators in Ukraine for January 2018:
- Key macroeconomic indicators such as GDP, exports, imports and industrial production showed growth in January compared to the same period last year, while retail sales and unemployment rate remained stable.
- In the pharmaceutical market, imports increased by 35% in January 2018 compared to January 2017, while retail sales values grew by 21% and volumes by 5%. Exports also increased by 19% year-on-year.
- The average cost of a pharmaceutical pack rose by 15% in January 2018 versus the same month of the previous year, while the consumer price index for pharmaceutical products increased by 6.4% year-
"Highlights":
Consumer prices are on the rise though annual inflation remains negative
Surplus in the current account for the second consecutive quarter
Lending is back
"In Focus":
Macroeconomic forecasts, by: Igors Kasjanovs
We are glad to share with you the Global M&A Partners' Industrial Insider our quarterly report on M&A transactions. Should you have any queries or M&A project, please contact your local Global M&A Partners industrial sector team member.
Celem artykułu jest analiza polityki handlowej Unii Europejskiej wobec Chin w kontekście
zmian jakie są związane z wygaśnięciem okresu przejściowego członkostwa Chin w WTO,
które nastąpiło w grudniu 2016 roku. Wygaśnięcie owego okresu przejściowego wymusza na
Unii Europejskiej pewne zamiany zwłaszcza w postępowaniach antydumpingowych. Dla zrealizowania celu pracy przyjęto że przyznanie lub nie statusu gospodarki rynkowej Chinom jest
przede wszystkim decyzją polityczną wymagającą uwzględniani sprzecznych interesów państw
członkowskich UE.
The pharmaceutical market of Uzbekistan is growing rapidly due to economic development and population growth. The market is currently estimated at $650-700 million but is forecast to double to $1.5 billion by 2020. Local manufacturers currently hold 20% market share while the remaining 80% is held by foreign manufacturers, primarily from Europe, the US, and India. The government is supporting development of domestic production through incentives for foreign investment. Key growth areas are expected to be generics, OTC drugs, and patented brands as consumer purchasing power increases. The market remains underdeveloped with a need for more modern medical facilities and a wider range of products across the country.
The Commonwealth of Independent States (CIS) region has a total GDP of approximately $1.6 trillion and a population of 276 million people. While the original drug market will grow more slowly than generics between 2010-2011, overall growth in original medicines will be positive. The pharmaceutical market is dominated by generic drugs, which make up around 85% of the market. Key players and market structure differ from Western markets, with almost a 50/50 split between Rx and OTC segments and strong local generic production, particularly in Ukraine.
Dear all,
I'm glad to share with you our quarterly report on M&A activities in the industrial segment, the Industrial Insider.
There is a special focus on the Industrial Internet Of Things, IOT.
Should you have any quieries, don't hesitate to contact your local Global M&A Partners' Industrials' sector team representative.
This report analyzes the pharmaceutical industry in Uruguay. Key points include:
1) The pharmaceutical sector has shown strong growth over the past decade, outpacing overall manufacturing and the national economy. Exports have also grown faster than total country exports.
2) The industry employs thousands of professionals and technicians and pays above-average wages. There are around 100 pharmaceutical companies in Uruguay, larger than average for national industries.
3) While exports have increased, imports remain greater than exports, resulting in a trade deficit. The main exports are medicines, blood products, and pharmaceutical preparations. Exports go mainly to Latin America.
4) The domestic market includes multinational and national/regional companies
The document summarizes the Ukrainian pharmaceutical market and reasons for starting a business there. It notes that Ukraine has a large pharmaceutical market with over $2.8 billion in retail sales in 2019. The market is growing in both monetary and physical terms. Foreign manufacturers are increasing their market share. Ukraine also offers low costs for doing business, a large workforce, and natural attractions for tourism. The agency provides various consulting services to help companies enter and succeed in the Ukrainian pharmaceutical market.
Global M&A Partners Industrial insider Q3 2018 focus on predictive maintenanceVeronique Zeid-Maurel
Happy to share with you our quarterly report on M&A activities in the industrial segment, there is a special focus on predictive maintenance. To know more, contact your local Global M&A Industrial sector team member. http://www.globalma.com/industry_sectors/industrials
Global M&A Industrial insider Q4 2018 industrial machine visionVeronique Zeid-Maurel
Happy to share with you our quarterly report on M&A activities in the industrial segment, there is a special focus on industrial machine vision.
To know more, contact your local Global M&A Industrial sector team member.
https://www.globalma.com/industry_sectors
Ukrainian Pharmaceutical Market Monthly - Upharmacia - Feb 2018Eirhub
This document provides an overview of macroeconomic indicators and pharmaceutical market indicators in Ukraine for January 2018:
- Key macroeconomic indicators such as GDP, exports, imports and industrial production showed growth in January compared to the same period last year, while retail sales and unemployment rate remained stable.
- In the pharmaceutical market, imports increased by 35% in January 2018 compared to January 2017, while retail sales values grew by 21% and volumes by 5%. Exports also increased by 19% year-on-year.
- The average cost of a pharmaceutical pack rose by 15% in January 2018 versus the same month of the previous year, while the consumer price index for pharmaceutical products increased by 6.4% year-
"Highlights":
Consumer prices are on the rise though annual inflation remains negative
Surplus in the current account for the second consecutive quarter
Lending is back
"In Focus":
Macroeconomic forecasts, by: Igors Kasjanovs
We are glad to share with you the Global M&A Partners' Industrial Insider our quarterly report on M&A transactions. Should you have any queries or M&A project, please contact your local Global M&A Partners industrial sector team member.
Celem artykułu jest analiza polityki handlowej Unii Europejskiej wobec Chin w kontekście
zmian jakie są związane z wygaśnięciem okresu przejściowego członkostwa Chin w WTO,
które nastąpiło w grudniu 2016 roku. Wygaśnięcie owego okresu przejściowego wymusza na
Unii Europejskiej pewne zamiany zwłaszcza w postępowaniach antydumpingowych. Dla zrealizowania celu pracy przyjęto że przyznanie lub nie statusu gospodarki rynkowej Chinom jest
przede wszystkim decyzją polityczną wymagającą uwzględniani sprzecznych interesów państw
członkowskich UE.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
La masa madre es un cultivo de levadura y bacterias que se utiliza para hacer pan casero. Se alimenta diariamente con harina y agua para que fermente de forma natural, lo que le da al pan un sabor más rico y nutritivo. La masa madre requiere atención y paciencia para mantenerla viva y saludable.
Muhammad Usman has worked as a Senior Hardware Engineer for Unified DLabs where he has experience developing firmware for ARM7 and Zigbee chipsets. Some of his responsibilities have included MISU firmware development and technical support for organizations like SSGC and SNGPL. He has also done work testing and troubleshooting ARM7 boards, meter reverse engineering, and field work installing and troubleshooting equipment on sites. He has experience interfacing with various hardware components and sensors. He has supported several student projects involving technologies like Zigbee, ARM7, and Xbee.
This document provides an overview of migration trends and data for Leeds. It summarizes statistics on arrivals to Leeds by country of origin over time. It also discusses programs to support migrants, including refugees resettling in Leeds from Syria. Challenges migrants may face are outlined, as well as opportunities migration brings. Resources are listed to help services support migrants.
Revenues for WashTec AG for the first three quarters of 2014 were €216.2 million, a decrease of 1% from the prior year. Earnings before interest and taxes (EBIT) increased to €11.8 million compared to €8.9 million in the prior year period, driven by positive business development in the company's core European markets. While revenues declined slightly in Eastern Europe and North America, they increased in core Europe, particularly in the services and chemicals segments. The company aims to achieve stable revenues for the full year with a slight increase in earnings and EBIT margin.
Metrics, Best Practices and Tools used in managing site performance. Understand usage of NAV timing metrics, synthetic versus real user monitoring, and performance budgeting.
Ukrainian Pharmaceutical Market Monthly - Upharmacia - Jan 2018Eirhub
The document provides an overview of the Ukrainian pharmaceutical market indicators for December 2017. Key points include:
- Pharmaceutical exports grew 6% in 2017 to $193.4 million while imports increased 10% to $1767.3 million.
- Retail sales in values grew 16.5% in 2017 to $2731 million and volumes increased 6% to 1685 million units.
- The average cost of a pharmaceutical pack was $1.47 in 2017.
EU: Vaccines For Human Medicine - Market Report. Analysis And Forecast To 2020IndexBox Marketing
This document provides a summary of a sample report on the EU vaccines for human medicine market from 2007 to 2015. It includes key findings on market value, production, imports, and exports in 2015. The executive summary highlights trends in the market and trade balance. The market overview section analyzes the market size, structure, and trade patterns. Tables and figures present historical data on production, trade, prices, and industry structure.
Forecast of development of ukrainian economy in 2017Anatoliy Amelin
The Ukrainian economy showed moderate growth in 2016, with GDP expected to increase 1.1% for the year. Inflation eased to an expected 12% for 2016. Exports stagnated due to relatively low commodity prices. Imports of goods continued to decline, while investment imports increased, signaling positive trends. However, exports declined faster than imports, resulting in a negative trade balance that is expected to widen to $4.9 billion, or 5% of GDP. Overall the recovery remains weak, with investment and domestic demand still low. Continued reforms are needed to strengthen energy independence and improve competitiveness.
The document summarizes the current state and future prospects of the health care industry in Russia and the region of Tatarstan. It outlines that the Russian market is large and growing, with an aging population driving increased demand. The government is undertaking major reforms through 2020 to encourage local production, R&D, and increase spending. This includes legal changes favoring domestic manufacturers and 4.2 billion in investments. The region of Tatarstan is highlighted as a success story within Russia's health care industry.
This paper discloses major developments of Ukrainian foreign trade for the recent years, shows the behavior of main factors which influenced foreign trade, presents results of modeling as well as short-term forecasts.
In this paper we describe the structure of Ukrainian merchandise trade, exchange rate movements and their impact on the merchandise trade balance. Then we discuss developments of the world economy and forecasts for international trade. Finally, we present the model of Ukrainian merchandise foreign trade followed by the forecasts produced by the model.
From the practical point of view, our work was aimed at building a model that would help to predict the influence of the price (real exchange rate) and income (GDP) changes both domestically and abroad on the Ukrainian Merchandise Trade. The results were planned to use in the monthly and quarterly models of Ukrainian economy developed and operated by CASE and Ukrainian government.
Authored by: Yurij M. Kuz'myn
Published in 2000
1. Ukraine's economy has experienced solid recovery in recent years, with real GDP growth accelerating to 3.3% in 2018. Private consumption has been the key driver of growth.
2. Reforms have supported economic recovery and Ukraine has taken steps to diversify its trade partners, with the EU becoming its largest trading partner. Exports of goods like machinery and metals increased substantially in 2018.
3. The document provides an overview of Ukraine's economy and recent economic performance but cautions that it does not constitute an offer to invest and contains forward-looking statements that may not reflect actual results.
1. Ukraine's economy has been recovering well, with real GDP growth of 3.3% in 2018, driven by strong consumer demand and increasing investments.
2. Key reforms have supported Ukraine's economic recovery and established irreversible steps toward change, while fiscal consolidation has helped prudent debt management.
3. Continued support from economic partners has also contributed to Ukraine's solid economic recovery track over recent years.
The document provides an economic overview and outlook for Ukraine in 2017. It summarizes that the Ukrainian economy has stabilized over the past year and entered 2017 poised for accelerated growth, supported by recovery in domestic demand and consumption. Inflation is projected to remain in the low double digits through 2017, fueled by utility tariff increases. External accounts will remain challenging due to imports outpacing exports, but the IMF program is on track and sovereign borrowings are expected to cover any current account deficit. Overall, the economy is projected to see GDP growth of 2.8% in 2017 on strengthening domestic demand.
Flash Report - Hungarian Inflation - 11 April 2018OTP Bank Ltd.
2%-ra emelkedett az éves bázisú fogyasztói árindex márciusban, azonban továbbra is számos hatás fékezi az árnyomás erősödését. Idén 2% közelében maradhat az infláció, jövőre azonban akár gyors emelkedést is láthatunk, ha az egyszeri tételek hatása kifut.
The document summarizes the economic challenges facing Catalonia due to the independence movement. It notes that business creation in Catalonia has fallen 54.5% since March 2017. Over 1,500 companies have moved headquarters due to political instability, representing 85% of Catalonia's market capitalization. An independent Catalonia would face tariffs, credit contraction, loss of EU funds, and increased unemployment of up to 30%.
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVedanta A
Air Ambulance Services In Rewa works in close coordination with ground-based emergency services, including local Emergency Medical Services, fire departments, and law enforcement agencies.
More@: https://tinyurl.com/2shrryhx
More@: https://tinyurl.com/5n8h3wp8
Fit to Fly PCR Covid Testing at our Clinic Near YouNX Healthcare
A Fit-to-Fly PCR Test is a crucial service for travelers needing to meet the entry requirements of various countries or airlines. This test involves a polymerase chain reaction (PCR) test for COVID-19, which is considered the gold standard for detecting active infections. At our travel clinic in Leeds, we offer fast and reliable Fit to Fly PCR testing, providing you with an official certificate verifying your negative COVID-19 status. Our process is designed for convenience and accuracy, with quick turnaround times to ensure you receive your results and certificate in time for your departure. Trust our professional and experienced medical team to help you travel safely and compliantly, giving you peace of mind for your journey.www.nxhealthcare.co.uk
Solution manual for managerial accounting 18th edition by ray garrison eric n...rightmanforbloodline
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressed
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressed
Test bank clinical nursing skills a concept based approach 4e pearson educati...rightmanforbloodline
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
The Importance of Black Women Understanding the Chemicals in Their Personal C...bkling
Certain chemicals, such as phthalates and parabens, can disrupt the body's hormones and have significant effects on health. According to data, hormone-related health issues such as uterine fibroids, infertility, early puberty and more aggressive forms of breast and endometrial cancers disproportionately affect Black women. Our guest speaker, Jasmine A. McDonald, PhD, an Assistant Professor in the Department of Epidemiology at Columbia University in New York City, discusses the scientific reasons why Black women should pay attention to specific chemicals in their personal care products, like hair care, and ways to minimize their exposure.
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPTblessyjannu21
Prepared by Prof. BLESSY THOMAS, VICE PRINCIPAL, FNCON, SPN.
Emphysema is a disease condition of respiratory system.
Emphysema is an abnormal permanent enlargement of the air spaces distal to terminal bronchioles, accompanied by destruction of their walls and without obvious fibrosis.
Emphysema of lung is defined as hyper inflation of the lung ais spaces due to obstruction of non respiratory bronchioles as due to loss of elasticity of alveoli.
It is a type of chronic obstructive
pulmonary disease.
It is a progressive disease of lungs.
Research, Monitoring and Evaluation, in Public Healthaghedogodday
This is a presentation on the overview of the role of monitoring and evaluation in public health. It describes the various components and how a robust M&E system can possitively impact the results or effectiveness of a public health intervention.
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...Media Logic
When it comes to creating marketing strategies that target older adults, it is crucial to have insight into their media habits and preferences. Understanding how older adults consume and use media is key to creating acquisition and retention strategies. We recently conducted our seventh annual survey to gain insight into the media preferences of older adults in 2024. Here are the survey responses and marketing implications that stood out to us.
Basics of Electrocardiogram
CONTENTS
●Conduction System of the Heart
●What is ECG or EKG?
●ECG Leads
●Normal waves of ECG.
●Dimensions of ECG.
● Abnormalities of ECG
CONDUCTION SYSTEM OF THE HEART
ECG:
●ECG is a graphic record of the electrical activity of the heart.
●Electrical activity precedes the mechanical activity of the heart.
●Electrical activity has two phases:
Depolarization- contraction of muscle
Repolarization- relaxation of muscle
ECG Leads:
●6 Chest leads
●6 Limb leads
1. Bipolar Limb Leads:
Lead 1- Between right arm(-ve) and left arm(+ve)
Lead 2- Between right arm(-ve) and left leg(+ve)
Lead 3- Between left arm(-ve)
and left leg(+ve)
2. Augmented unipolar Limb Leads:
AvR- Right arm
AvL- Left arm
AvF- Left leg
3.Chest Leads:
V1 : Over 4th intercostal
space near right sternal margin
V2: Over 4th intercostal space near left sternal margin
V3:In between V2 and V4
V4:Over left 5th intercostal space on the mid
clavicular line
V5:Over left 5th intercostal space on the anterior
axillary line
V6:Over left 5th intercostal space on the mid
axillary line.
Normal ECG:
Waves of ECG:
P Wave
•P Wave is a positive wave and the first wave in ECG.
•It is also called as atrial complex.
Cause: Atrial depolarisation
Duration: 0.1 sec
QRS Complex:
•QRS’ complex is also called the initial ventricular complex.
•‘Q’ wave is a small negative wave. It is continued as the tall ‘R’ wave, which is a positive wave.
‘R’ wave is followed by a small negative wave, the ‘S’ wave.
Cause:Ventricular depolarization and atrial repolarization
Duration: 0.08- 0.10 sec
T Wave:
•‘T’ wave is the final ventricular complex and is a positive wave.
Cause:Ventricular repolarization Duration: 0.2 sec
Intervals and Segments of ECG:
P-R Interval:
•‘P-R’ interval is the interval
between the onset of ‘P’wave and onset of ‘Q’ wave.
•‘P-R’ interval cause atrial depolarization and conduction of impulses through AV node.
Duration:0.18 (0.12 to 0.2) sec
Q-T Interval:
•‘Q-T’ interval is the interval between the onset of ‘Q’
wave and the end of ‘T’ wave.
•‘Q-T’ interval indicates the ventricular depolarization
and ventricular repolarization,
i.e. it signifies the
electrical activity in ventricles.
Duration:0.4-0.42sec
S-T Segment:
•‘S-T’ segment is the time interval between the end of ‘S’ wave and the onset of ‘T’ wave.
Duration: 0.08 sec
R-R Interval:
•‘R-R’ interval is the time interval between two consecutive ‘R’ waves.
•It signifies the duration of one cardiac cycle.
Duration: 0.8 sec
Dimension of ECG:
How to find heart rhytm of the heart?
Regular rhytm:
Irregular rhytm:
More than or less than 4
How to find heart rate using ECG?
If heart Rhytm is Regular :
Heart rate =
300/No.of large b/w 2 QRS complex
= 300/4
=75 beats/mins
How to find heart rate using ECG?
If heart Rhytm is irregular:
Heart rate = 10×No.of QRS complex in 6 sec 5large box = 1sec
5×6=30
10×7 = 70 Beats/min
Abnormalities of ECG:
Cardiac Arrythmias:
1.Tachycardia
Heart Rate more than 100 beats/min
Cyclothymia Test: Diagnosing, Symptoms, Treatment, and Impact | The Lifescien...The Lifesciences Magazine
The cyclothymia test is a pivotal tool in the diagnostic process. It helps clinicians assess the presence and severity of symptoms associated with cyclothymia.
1. Ukrainian Pharmaceutical Market Monthly
Upharmacia
Macroeconomic Environment | Market &
Companies News | Regulatory Updates |
Healthcare News
Issue: 12 2015
UPharma Consulting is a consulting company, operating in the healthcare and pharma sectors. Our
clients - pharmaceutical companies, pharmacy chains, distributors, investment funds, banks, and
other stakeholders in the healthcare sector.
UPharma Consulting, Kiev
www.upharma-c.com / mailbox@upharma-c.com
2. Page 2
Ukrainian Pharmaceutical Market Monthly: December 2015
MACROECONOMIC ENVIRONMENT
Description of the indicators:
Macroeconomic Indicators
GDP (Gross Domestic Product) is an aggregate measure of production equal to the sum of the gross
values added of all resident, institutional units engaged in production (plus any taxes, and minus
any subsidies, on products not included in the value of their outputs) calculated in current prices.
Converted from UAH to USD in accordance with an average official NBU exchange rate in the
corresponding period. Hereinafter: excluding the temporarily occupied territory of the Autonomous
Republic of Crimea and City of Sevastopol, as well as the part of zone of the antiterrorist operation.
Source: State Statistics Service of Ukraine.
Export of goods is a sale of goods by Ukrainian subjects of foreign economic activities to foreign
subjects of foreign economic activities (including non-cash payment) with or without exportation
of these goods through the customs border of Ukraine, including the re-export of goods. Initially
calculated in USD. Source: State Statistics Service of Ukraine.
Import of goods is a purchase (including non-cash payment) of goods by Ukrainian subjects of foreign
economic activities in foreign subjects of economic activities with or without the importation of these
goods into the territory of Ukraine, including the purchase of goods for domestic consumption by
establishments and organizations of Ukraine located abroad. Initially calculated in USD. Source: State
Statistics Service of Ukraine.
Industrial production sales is the value of industrial goods, which are actually shipped in the period, as
indicated in documents decorated as the basis for calculating with the buyer (customer), regardless of
income payments for them. Converted from UAH to USD in accordance with an average official NBU
exchange rate in the corresponding period. Source: State Statistics Service of Ukraine.
Retail turnover of enterprises is the value of consumer goods sold via retail trade and restaurants to
the population by all operating enterprises. It also includes direct retail sales by industrial, transport
and other non-trade enterprises. In addition, retail turnover includes retail sales of food products to
departments, organizations and enterprises to provide meals to the people they serve (at sanatoria,
children’s care institutions, hospitals, etc.). Reflected in current prices. Converted from UAH to USD
in accordance with an average official NBU exchange rate in the corresponding period. Source: State
Statistics Service of Ukraine.
Unemployment rate is a ratio (percent) of the unemployed registered at the State Employment Service
to the average annual population of working age. Source: State Statistics Service of Ukraine.
Average salary is an average value of remuneration in cash and in kind paid to employees for time
worked or work done. Converted from UAH to USD in accordance with an average official NBU
exchange rate in the corresponding period. Source: State Statistics Service of Ukraine.
Official currency exchange rate is the rate established by the National Bank of Ukraine under which
Ukrainian national currency – UAH (Ukrainian hryvnia) will be exchanged for foreign currency (USD or
EUR). Calculated as average value in the corresponding period. Source: National Bank of Ukraine.
Pharmaceutical Industry Indicators
Export of pharma products is an export of goods related to the group “Pharmaceutical products” under
the Ukrainian Classification of Goods for Foreign Economic Activities. Initially calculated in USD.
Source: State Statistics Service of Ukraine.
Import of pharma products is an import of goods related to the group “Pharmaceutical products” under
the Ukrainian Classification of Goods for Foreign Economic Activities. Initially calculated in USD.
Source: State Statistics Service of Ukraine.
Pharma retail sales are retail sales of different product categories of “pharmacy basket” (drugs,
medical devices, cosmetics and food supplements) in values and volumes. Converted from UAH to
USD in accordance with an average official NBU exchange rate in the corresponding period. Source:
Morion.
WACP (Weighted average cost of a pack) is a ratio of pharma retail sales in values to pharma retail
sales in volumes.
CPI (Consumer price index) is an indicator of changes at the time of prices and tariffs for commodities
and services being purchased by the population for unproductive consumption calculated to
corresponding month of previous year. Source: State Statistics Service of Ukraine.
Pharma products CPI is a Consumer price index of “Pharmaceutical products, medical products,
appliances and equipment” group calculated to corresponding month of previous year. Source: State
Statistics Service of Ukraine.
Local companies share is the share (percent) of sales related to Ukrainian companies in overall pharma
retail sales in values and volumes. Source: Morion
Table: Key macroeconomic
indicators in Ukraine (Jan-Nov 2015)
2015
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov
MACROECONOMIC INDICATORS
Q1 Q2 Q3
GDP (bn USD) 17.353 20.795 25.552
GDP growth, % y-o-y -51% -35% -26%
Export of goods (bn USD) 2.98 2.99 3.45 3.07 2.94 3.09 3.15 3.09 3.35 3.23 3.13
Export growth, % y-o-y -32% -37% -32% -39% -41% -30% -34% -22% -22% -23% -21%
Import of goods (bn USD) 3.01 2.86 3.17 2.86 2.63 2.76 2.98 3.88 3.24 3.22 3.07
Import growth, % y-o-y -34% -41% -35% -38% -46% -37% -34% -2% -30% -27% -27%
Industrial production sales (bn USD) 6.01 4.56 5.51 5.91 5.65 5.79 5.71 5.42 5.72 6.29 5.92
Industrial production growth, % y-o-y -41% -54% -45% -33% -38% -35% -33% -23% -20% -21% -19%
Retail turnover of enterprises (bn USD) 1.97 1.44 1.61 1.66 1.94 1.83 1.94 1.88 1.86 2.04 1.80
Retail turnover growth, % y-o-y -50% -61% -56% -40% -35% -38% -41% -32% -38% -31% -33%
Unemployment rate 2.0 2.0 1.9 1.8 1.8 1.7 1.6 1.6 1.5 1.5 1.6
Average salary (USD) 218 148 166 176 193 202 202 194 199 207 193
OFFICIAL CURRENCY EXCHANGE RATE
UAH/USD 15.8 24.5 23.3 22.7 20.9 21.2 21.8 21.6 21.8 21.8 23.31
UAH/EUR 18.5 27.8 25.3 24.5 23.3 23.8 23.9 24.0 24.5 24.6 25.07
PHARMACEUTI CAL INDUSTRY INDICATORS
Export of pharma products (mio USD) 11.79 12.05 13.37 13.46 13.00 15.36 13.85 9.01 13.79 12.2 11.7
Pharma Export growth, % y-o-y -1% -42% -50% -44% -39% -39% -6% -54% -47% -37% -52%
Import of pharma products (mio USD) 90.2 114.5 103.3 103.7 84.2 115.0 106.5 93.3 121.1 147.14 141.25
Pharma Import growth, % y-o-y -49% -47% -67% -36% -60% -44% -47% -47% -31% -28% -24%
Pharma retail sales, values (mio USD) 239.8 177.0 197.6 180.0 193.0 177.7 172.6 177.1 193.2 206.3 196.6
Retail sales in values growth, % y-o-y -41% -54% -47% -40% -28% -29% -32% -24% -28% -26% -20%
Pharma retail trade, volumes (mio units) 132.4 143.9 141.5 122.6 124.5 118.4 119.5 122.5 126.7 130.2 129.0
Retail sales in volumes growth, % y-o-y -21% -15% -21% -20% -11% -9% -10% -8% -11% -5% -4%
WACP, USD 1.95 1.81 1.24 1.41 1.47 1.52 1.48 1.45 1.52 1.58 1.52
WACP growth, % y-o-y -21% -22% -40% -27% -23% -21% -23% -18% -19% -22% -18%
CPI of Ukraine 128.5 134.5 145.8 160.9 158.4 157.5 155.3 152.8 151.9 146.4 138.1
Pharma products CPI 149.2 155.5 170.3 164.7 159.5 153.5 151.8 149.4 145.8 142.1 146.6
Local companies share, values, % 38.7 38.5 39.6 40.7 41.5 41.7 41.8 41.4 41.4 41.4 41.7
Local companies share, volumes, % 74.9 75.2 77.1 77.6 77.6 77.9 78.4 78.2 76.5 75.7 75.8
3. Page 3
Ukrainian Pharmaceutical Market Monthly: December 2015
KEY ECONOMIC EVENTS
»» On Dec 25, the 2016 Draft Budget and the Tax Code were approved by the Ukrainian parliament. The compromise
version of the Tax Code foresees the cut of payroll tax from 37% to 20%, decrease of personal income tax from
18% to 15%, enterprise profit tax and VAT are to remain unchanged, 17% and 20% respectively. Preference VAT
rate for drugs is also to maintain its reduced rate of over 7%.
»» The 2016 Budget deficit is projected at 3.7% of GDP, with UAH 601.4 bn revenues. Spending cuts targeted
education and healthcare, while increases were earmarked for the army, police and housing.
»» Ukraine PM indicated seven main tasks for Ukraine in 2016, which are: reforming secondary school education,
reforming health care, conducting privatization of state enterprises, implementing tax reform, extending
decentralization, fulfilling the EU free trade area and implementing the EU visa-free regime. These goals were
agreed with the American Chamber of Commerce in Ukraine, Mr. Yatsenyuk said.
»» The IMF mission made a decision to change its landing policy in Ukraine’s favor, meaning it will continue provision
of tranches to Ukraine, despite its Russian USD 3 bn Eurobond debt. The Russian officials did not approved the
decision, saying Russia is willing to defend its interests in court.
»» The date of the next IMF tranche arrival is still uncertain as its officials still need to study Ukraine’s Budget,
the Minister of Finance said. Despite the Budget submitted to the parliament met all IMF requirements, it is still
unclear how the IMF will evaluate the amendments made to it, Mrs. Jaresko stated.
»» Industrial production fell 4.9% y-o-y in Nov, with slight improvement in machinery production (4% y-o-y). Lugansk
region showed 61% y-o-y surplus in production growing. Sales of industrial production fell 19% y-o-y in Nov.
»» Agreement between Ukraine and the EU on the deep and comprehensive free trade zone is to enter into force
since Jan 1, 2016. The agreement will eliminate 97% tariffs on Ukrainian goods and reduce the average tariff on
Ukrainian exports from 7.6% to 0.5%. Subsequently, since Jan 2, 2016, Ukraine exits the free trade zone with
Russia and reduces duties on all Russian products.
»» Ukraine’s Economy Ministry introduced the embargo of some Russian goods to be in force since Jan 10, 2016,
as a response to Russia’s cancelation of its free trade area with Ukraine and imposition of embargo on Ukrainian
agriculture and food products. Ukraine’s embargo will relate to Russian food and beverages, some detergents,
fertilizers and plant protectors, railway equipment and diesel locomotives.
239.8
177.0
197.6
180.0
193.0
177.7
172.6
177.1
193.2
206.3
196.6
132.4
143.9
141.5
122.6
124.5
118.4
119.5
122.5
126.7
130.2 129.0
100
110
120
130
140
150
160
100
120
140
160
180
200
220
240
260
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov
Pharma retail sales
Values (mio USD) & Volumes (mio units)
Jan-Nov 2015
mio USD mio units
11.79 12.05
13.37 13.46 13.00
15.36
13.85
9.01
13.75
12.20
11.70
90.2
114.5
103.4 103.7
84.3
115.0
106.6
93.3
122.2
147.1
141.25
20
40
60
80
100
120
140
160
0
2
4
6
8
10
12
14
16
18
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov
Ukrainian Internation trade in pharma
production
Export & Import, mio USD
Jan-Nov 2015
Export Import
6.01
4.56
5.51
5.91
5.65 5.80 5.71
5.43
5.72
6.29
5.92
1.97
1.44 1.61 1.66
1.94
1.83
1.94 1.88 1.86
2.04
1.80
0.0
0.5
1.0
1.5
2.0
2.5
3.0
0
1
2
3
4
5
6
7
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov
Industrial production sales &
Retail turnover of enterprises surplus
Jan-Nov 2015, bn USD
Industrial production sales Retail turnover of enterprises
15.81
24.48
23.26 22.71
20.92 21.23 21.76 21.63 21.78 21.84
23.31
19.26
28.95 29.52
26.92
25.48 24.91
26.09 25.91 26.14
24.56 25.07128.5
134.5 145.8
160.9 158.4 157.5 155.3 152.8 151.9
146.4 146.6
0
20
40
60
80
100
120
140
160
180
0
5
10
15
20
25
30
35
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov
OFFICIAL CURRENCY EXCHANGE RATE
+Consumer Price Index
Jan-Nov 2015
UAH/USD UAH/EUR CPI of Ukraine
4. Page 4
Ukrainian Pharmaceutical Market Monthly: December 2015
MARKET & COMPANIES NEWS
Pharmaceuticals and medicine are
among the most perspective fields
in Ukraine for foreign investors
In the nearest future,
pharmaceutical industry and
medicine are to be among TOP-5
industries, foreign investors will
consider as the most attractive
ones, “Economic truth” publication
states. Last year the capital
investments in pharmaceutical
companies increased by 19.7%
y-o-y.
Foreign investors note the
presence of qualified staff
potential, relatively unoccupied
market and government programs
to support businesses in the
pharmaceutical field, “Concorde
capital” investment company
director Igor Mazepa said. They
also deem Ukrainian production
capacities have considerable
potential for extension being
able to produce a wide range of
products according to the latest
world standards.
“Arterium”
is developing
drugs for military and emergency
medicine
“Arterium corp.” started
development of drugs, which
could be used is military and
emergency medicine considered
as perspective. As the
development stage could take
3-4 years, the company does not
forecast an approximate date of
the drugs launching.
After the company’s hemostatic
drug Tramix (tranexamic acid)
had been launched in late 2014,
its sales were estimated at 9 ths.
of units, in volumes. “Arterium’s”
drugs are actively used in the
antiterrorist operation zone, as
the company gratuitously supplies
preparation to the needs of
military hospitals, “Arterium’s”
officials stated.
“Arterium corp.” is the 4th
company on Ukrainian
pharmaceutical market, portfolio
of which consists of 148 generic
and several original drugs in 11 of
14 ATC groups.
GlaxoSmithKline
is creating the
CIS cluster
GlaxoSmithKline announced
that since January 1, 2016, the
company’s representatives in
Azerbaijan, Georgia, Kazakhstan
and Middle Asia (Uzbekistan and
Kirgizstan) are subordinated to
Regional general Director of GSK
in Ukraine and BMA (Belarus,
Moldova, Armenia) Serkan
Yagcioglu.
Therefore, the new CIS cluster
will be created in MENA/CIS
(Middle East, North Africa and
CIS) region, witch gives the
opportunities for mutual support
between the offices in the
countries included.
As the markets of Azerbaijan,
Georgia, Kazakhstan and Middle
Asia have similar dynamics,
including them into new cluster
with Ukraine and BMA will make
the operating model more simple
and clear, Senior Vice President
of GSK and Director of MENA/
CIS region Fabio Landazabal
commented.
General Director in Turkey,
Azerbaijan and Georgia Emin
Fadillioglu will be responsible for
Turley only since 2016.
“Borshchahivskiy
CPP” has
launched new antiallergic drug
Ukrainian 7th biggest company
“Borschagovsky CPP” launched
antiallegric drug Alerdez
(desloratadine) to cure nasal
allergy and urticaria such as
itching and rashes.
“BCPP” is a 16th company on
Ukrainian pharmaceutical market
as of 9M2015. It has improved its
position form 19th place PPG. The
company is basically specialized in
cardio drugs, while preparations
for respiratory system take about
7% in its portfolio.
“Darnitsa” is
allowed to buy a
share of “Borshchahivskiy CPP”
Antimonopoly Committee of
Ukraine has allowed “Darnitsa”
pharmaceutical company to
acquire more than 25% of
shares of “Borshchahivskiy
CPP”. Previously, on March
20, 2015, Financial Company
“Kub”, representing “Darnitsa’s”
interests, acquired 29.95% of
shares of “BCPP” on the auction
for UAH 171.8 mio. After the
auction “Darnitsa” announced that
it intends to promote the goals
and policies of the “BCPP”.
Experts expect that “Darnitsa”
associates with “BCPP” in the
medium term, which could lead
to increase of competition on the
Ukrainian pharmaceutical market.
“Darnitsa” was the third company
on the market as of 2014 and is
expected to improve its position
in 2015 rating. In 2015, the
company’s officials confirmed
they want to integrate “BCPP” and
“Kiev Vitamin Factory” into the
“Darnitsa’s” structure, as it used
to be until 1994.
5. Page 5
Ukrainian Pharmaceutical Market Monthly: December 2015
REGULATORY UPDATES
On Dec 10, the Draft Law of
Ukraine “On Amendments to
certain legislative acts of Ukraine
on legislation improvement
on healthcare” regarding the
autonomization of healthcare
establishments was registered
in the Ukrainian parliament. The
Draft Law is an alternative to the
projects submitted by the Cabinet
of Ministers of Ukraine dated
07.07.2015 and by the Deputy
Oleg Musiy dated 17.07.2015.
After on Sept 16 the Parliament
Healthcare Committee sent the
alternative Draft Law back for
revision, the new improved one
was approved by Deputies.
The Draft Law defines the
legal forms of healthcare
establishments, sources of
financing of medical care
provision, requirements to
constituent documents, as
well as simplifies the order
of reorganizing of healthcare
establishments, etc. Unlike the
previous versions, the Draft
Law foresees state, municipal
and private forms of ownership
healthcare establishments could
have. Private establishments are
not limited in the choice of legal
and organizational form.
The Draft Law also indicates that
all healthcare establishments
could use funds raised from
entities and individuals and to set
fees for medical services based
on the method of calculation of
the cost of medical services.
Therefore, under the Draft Law
the funds are now be managed
by healthcare establishments
themselves.
--
On Dec 31, the Order #764 of the
MOH “On Amendments to the list
of goods, which pharmacies and
their structural units have a right
to purchase and sell” dated Nov
23, 2015 has entered into force.
The assortment of goods
pharmacies can purchase and sell
included following positions:
»» instruments, devices for oral,
skin, nails and hair care;
»» items and means for
aromatherapy (aroma lamps,
oil sticks, candles);
»» products of cotton wool
(cotton swabs, discs,
plates) feminine care
means, adhesives, paper
handkerchiefs, paper and
wet wipes, toilet paper, paper
towels, hosiery knitwear,
packaging materials, which
are not registered as medical
products;
»» tools, devices and other
products to combat addictions;
»» laboratory glassware,
pharmacy scales;
»» capacities of thermal insulation
material to maintain the
temperature during transport
(cold boxes, thermo bag,
thermo boxes), ice packs,
card-indicators, termo testers
freeze indicators;
It is expected that the
amendments approved will
contribute to the sale of actual
goods, including for people living
in rural areas; and also improve
the efficiency of the pharmacies’
activity through increased sales
volumes.
--
On Dec 9, the European Business
Association sent an open letter
to the members of the Parliament
Healthcare Committee regarding
the combined version of the
Draft Law of Ukraine “On Drugs”
being announced for propositions
on Nov 26. According to the
Ukrainian business community,
the new combined version of
two Draft Laws (#2162 dated
Feb 15, 2015 and #2162-1 dated
Mar 2, 2015) needs a thorough
processing regarding following
issues:
»» formulation of terms “State
control over the quality of
drugs” and “Regulation of
clinical trials” to not give the
opportunities for corruption
abuses;
»» compliance of certain
provisions with Directive
2001/83/EU of the European
Parliament and of the
European Council dated
November 6, 2001;
»» use of unspecified references
to some International
regulations;
»» the lack of consideration of the
current conditions the market
is working in and no provision
of appropriate transitional
periods, which is a standard
practice for the EU;
»» absence of the provisions
aimed at deregulation of the
pharmaceutical market to have
a positive impact regarding the
accessibility quality, effective
and safe medicines in Ukraine.
--
On Dec 23, the Resolution of
the Cabinet of Ministers of
Ukraine (the CMU) #1144 “On
Amendments to the Resolution
of the CMU #73 dated Mar 5,
2015” regarding pilot-project of
state regulation of insulin prices
was issued. According to the
Resolution, since Apr 1, 2016,
insulin preparations turnover
and their reimbursement at
the expense of local budgets, is
carried out at the reference prices
(reimbursement prices) after such
preparations are enlisted in the
register of reference prices in due
course.
Additionally, the MOH is assigned
to approve the Regulation on
registry of patients requiring
insulin and until Feb 1, 2016,
and bring it into force until Apr
6. Page 6
Ukrainian Pharmaceutical Market Monthly: December 2015
1, 2016. The MOH also has to
compile and promulgate the
register of reference prices on
insulin preparations until Apr 1,
2016 and by Mar 1, to submit the
Draft Act on insulin preparations
reimbursement since Apr 1, 2016.
--
Under the Resolution #1024 “On
Approval of provision standard of
inpatient hospital beds per 10 ths
of population” dated Nov 25, the
Cabinet of Ministers of Ukraine
has decreased the standard
number of hospital beds per 10
ths of population from 80 to 60.
The MOH will need to develop
the methodology of provision
of hospital beds to population,
under which the Regional State
administrations shrink the
number of hospital beds. Since
1999, the standard number of
hospital beds in Ukraine was 80
per 10 ths of population.
HEALTHCARE NEWS
The compromise Tax Code is
to maintain 7% VAT on the
pharmaceuticals
The Draft Code registered by
the Ministry of Finance provides
a preference 7% VAT rate on
pharmaceutical production.
Thereby, the Ministry heeded
the pharmaceutical community
stating expected 20% VAT rate
on pharmaceuticals, will lead
to significant cuts in revenues
and make foreign companies to
leave Ukrainian market. It is also
proposed to increase the VAT
registration threshold to UAH 2
mio.
The Government cut healthcare
expenditures in 2016
The 2016 Budget provides
UAH 44 bn expenditures on
healthcare, which is UAH 2 bn
less than year before. About 99%
of the funds are to be allocated
to local budgets. UAH 13.2 bn
are to be spend on the MOH
system funding. Additionally,
the PM of Ukraine recognized
the failure in health care reform
and considered the stabilization
of prices as a main task for
the government in 2016. Mr.
Yatsenyuk deems the stabilization
of prices and increase of social
standards are to compensate
difficulties caused by the increase
of tariffs.
The Minister of Healthcare of
Ukraine made conclusions on the
work made in 2015
At the special conference on Dec
21, Alexander Kvitashvili stated
that in 2015 the MOH achieved
significant changes in reforming
the pharmaceutical market
in terms of provision of the
population with quality medicines
and vaccines, established
legislative foundations for a new
state policy aimed at changing the
functioning of medical institutions
and fair financing system,
improvement of health services
and started a formation of a new
system of public health. The MOH
simplified the process of drugs
registration by reducing its role in
the registration procedures, the
Deputy Minister of Healthcare
Olexandra Pavlenko said. A
unified National Drugs list was
also created in 2015; as well new
licensing conditions of economic
activity in the area of medical
practice were introduced. Another
achievement was creation of the
Register of insulin-dependent
patients under the reimbursement
system implementation since
2016.
Another important reform was
a change in public procurement
system and start of cooperation
with International organizations
in this field. In public healthcare
field, the MOH achieved the
creation of the Center of
Public Health, resumption of
construction of a new medical-
diagnostic complex of children
hospital “OKHMATDYT”, and
managed to promptly and
systematically respond to the
challenge of polio outbreak in
Ukraine.
The MOH Head also indicated
priorities for 2016:
»» modernization of primary
healthcare and improvement of
work conditions for physicians;
»» creation of modern operational
and dispatching departments
in the centers of emergency
medical care and catastrophe
medicine in most regions of
Ukraine;
»» transfer of 100% of the funds
7. Page 7
Ukrainian Pharmaceutical Market Monthly: December 2015
for drugs to International
organizations to ensure
uninterrupted provision of
population with medicines and
vaccines;
»» implementation of the insulin
reimbursement system for
patients with diabetes;
»» change of activity mechanisms
for state and municipal
healthcare institutions towards
their autonomization through
the adoption of appropriate
Laws;
»» implementation of guaranteed
package of medical services
to be financed from the state
budget
»» provision of valuable work
of the Centre of Public
Health, which is responsible
for disease prevention and
surveillance in the country;
»» completion of the new building
of the children’s hospital
“OKHMATDYT”;
»» developing of approaches to
reform the system of doctors
graduate and postgraduate
training.
A. Kvitashvili said he is not going
to leave his post
The Minister of Healthcare of
Ukraine Alexander Kvitashvili
said he is not going to leave his
post, even after the Ukrainian
Parliament failed to endorse his
dismissal four times since his
appointment in Dec 2014. In Jul
2015, Mr. Kvitashvili wrote a
resignation latter, hoping it would
help to approve the healthcare
reform legislation the MOH had
been fostering, but his work did
not change since then. “I came
to Ukraine to work, having an
experience of practical changes
in Georgia, that is why, if I do not
have a support I should have,
it would be logical to leave,” the
Minister said. “But now something
has changed and some support
has appeared.”
Mr. Kvitashvili also said he does
not know anything about possible
appointment of Deputy Oleksiy
Honcharenko to the post of the
Minister of Healthcare.
The World Bank will lend Ukraine
$170 mio to support primary
medicine
Ukraine will receive $170 mio
for primary medicine equipment
procurement, the Deputy Minister
of Healthcare of Ukraine Igor
Pereginets stated. “Primary
medicine system improvement
is among the main goals in
healthcare reformation,” Mr.
Pereginets said. “The MOH will
increase financing of primary
care in regions and villages up
to 35% and in cities of regional
importance up to 20-25%. The
World Bank’s project will help us
to procure necessary medical
equipment for this aid.”
The World Bank is also going to
allocate $215 mio during next
5 years to finance Ukrainian
healthcare system.